TEM-89 β-Lactamase Produced by a Proteus mirabilis Clinical Isolate: New Complex Mutant (CMT 3) with Mutations in both TEM-59 (IRT-17) and TEM-3

TEM-89 (CMT-3) is the first complex mutant β-lactamase produced by a clinical strain of Proteus mirabilis (strain Pm 631). This new enzyme, which has a pI of 6.28, is derived from TEM-3 and has a single amino acid substitution also encountered in TEM-59 (inhibitor-resistant TEM β-lactamase IRT-17):...

Szczegółowa specyfikacja

Opis bibliograficzny

Wydane w:	Antimicrob Agents Chemother
Główni autorzy:	Neuwirth, Catherine, Madec, Stephanie, Siebor, Eliane, Pechinot, Andre, Duez, Jean-Marie, Pruneaux, Michele, Fouchereau-Peron, Martine, Kazmierczak, Antoine, Labia, Roger
Format:	Artigo
Język:	Inglês
Wydane:	American Society for Microbiology (ASM) 2001
Hasła przedmiotowe:	Mechanisms of Resistance
Dostęp online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90874/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11709345/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.12.3591-3594.2001
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!